New concepts in the pathogenesis of alcoholic liver disease

Expert Review of Gastroenterology and Hepatology

Volumn 2, Issue 6, 2008, Pages 749-759

  Albano, Emanuele ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Adipokine; Apoptosis; CYP2E1; Ethanol; Hepatic stellate cell; Kupffer cell; Liver fibrosis; Oxidative stress; Steatosis

Indexed keywords

ALCOHOL; ALDEHYDE DEHYDROGENASE ISOENZYME 2; CANNABINOID 1 RECEPTOR; CD14 ANTIGEN; CYTOCHROME P450 2E1; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; NATURAL KILLER CELL RECEPTOR NKG2D; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; S ADENOSYLMETHIONINE; SIRTUIN 1; SONIC HEDGEHOG PROTEIN; STAT3 PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR NRF2; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; VERY LOW DENSITY LIPOPROTEIN;

ALCOHOL ABUSE; ALCOHOL LIVER DISEASE; ALCOHOL METABOLISM; CD4+ T LYMPHOCYTE; CELL DEATH; CELL PROLIFERATION; CYTOKINE PRODUCTION; DISEASE COURSE; ENDOPLASMIC RETICULUM STRESS; FATTY ACID OXIDATION; FATTY LIVER; GLUTATHIONE METABOLISM; HEPATITIS; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; INFLAMMATION; INSULIN RESISTANCE; KUPFFER CELL; LIVER FIBROSIS; LIVER NECROSIS; LIVER REGENERATION; LIVER TOXICITY; NATURAL KILLER T CELL; NONHUMAN; OXIDATIVE STRESS; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE ACTIVATION; LIVER CIRRHOSIS; PATHOPHYSIOLOGY; PHYSIOLOGY;

FATTY LIVER; HEPATITIS, ALCOHOLIC; HUMANS; INFLAMMATION; LIVER CIRRHOSIS; LIVER DISEASES, ALCOHOLIC; OXIDATIVE STRESS;

EID: 61549111852     PISSN: 17474124     EISSN: None     Source Type: Journal    
DOI: 10.1586/17474124.2.6.749     Document Type: Review

References (96)

1. Tzukamoto H. Conceptual importance of identifying alcoholic liver disease as a lifestyle disease. J. Gastroenterol. 42, 603-609 (2007).
2. Sheron N, Oslen N, Gilmore I. An evidence based alcohol reduction policy. Gut 57, 1341-1344 (2008).
3. Yip WW, Burt AD. Alcoholic liver disease. Semin. Diagn. Pathol. 23, 149-160 (2006).
4. Wilfred de Alwis NM, Day CP. Genetics of alcoholic liver disease and non-alcoholic fatty liver disease. Semin. Liver Dis. 27, 44-54 (2007).
5. Lieber CS. Metabolism of ethanol. Clin. Liver Dis. 9, 1-35 (2005).
6. Lu Y, Cederbaum AL. CYP2E1 and oxidative liver injury by alcohol. Free Rad. Biol. Med. 44, 723-738 (2008).
7. Albano E. Alcohol, oxidative stress and free radical damage. Proc. Nutr. Soc. 65, 278-290 (2006).
8. Seitz HK, Stickel F. Molecular mechanisms of alcohol-mediated carcinogenesis. Nat. Rev. Cancer 7, 599-612 (2007).
9. Arteel GE. Oxidant and antioxidant in alcohol-induced liver disease. Gastroenterology 124, 778-790 (2003).
10. Harrison-Findik DD, Shafer D, Klein E et al. Alcohol metabolism-mediated oxidative stress down-regulates hepcidin transcription and leads to increased duodenal iron transporter expression J. Biol. Chem. 281, 22974-22992 (2006).
11. Gong P, Cederbaum AI. Nrf2 is increased by CYP2E1 in rodent liver HepG2 cells and protects against oxidative stress caused by CYP2E1. Hepatology 43, 144-153 (2006).
12. Lamlé J, Marhenke S, Borlak J et al. Nuclear factor-eythroid 2-related factor prevents alcohol-induced fulminant liver injury. Gastroenterology 134, 1159-1168 (2008).
13. Purohit V, Abdelmalek MF, Barve S et al. Role of S-adenosylmethionine, folate and betaine in the treatment of alcoholic liver disease: summary of a symposium. Am. J. Clin. Nutr. 86, 14-24 (2007).
14. Schröder M. Endoplasmic reticulum stress responses. Cell Mol. Life Sci. 65, 862-894 (2008).
15. Kaplowitz N, Than TA, Shinohara M, Ji C. Endoplasmic reticulum stress and liver injury. Sem. Liver Dis. 27, 367-377 (2007).
16. Malhotra JD, Kaufman RJ. Endoplasmic reticulum stress and oxidative stress: a vicious circle or a double-edged sword? Antiox. Redox Signal 9, 2277-2293 (2007).
17. Powel EE, Jonsson JR, Clouston AD. Steatosis: co-factor in other liver diseases. Hepatol. 42, 5-13 (2005).
18. You M, Crabb DW. Recent advances in alcoholic liver disease II. Minireview: molecular mechanisms of alcoholic fatty liver. Am. J. Physiol. Gastrointest. Liver Physiol. 287, G1-G6 (2004).
19. Esfandiari F, Villanueva JA, Wong DH, French SW, Halsted CH. Chronic ethanol feeding and folate deficiency activate hepatic endoplasmic reticulum stress pathway in micropigs. Am. J. Physiol. Gastrointest. Liver Physiol. 289, G54-G63 (2005).
20. You M, Liang X, Ajmo JM, Ness GC. Involvement of mammalian sirtuin 1 in the action of ethanol in the liver. Am. J. Physiol. Gastrointest. Liver Physiol. 294, G892-G898 (2008).
21. He L, Simmen FA, Ronis MJ, Badger TM. Post-transcriptional regulation of sterol regulatory element binding protein-1 by ethanol induces class I alcohol dehydrogenase in rat liver. J. Biol. Chem. 279, 28113-28121 (2004).
22. Rogers CQ, Ajmo JM, You M. Adiponectin and alcoholic fatty liver disease. IUBMB Life DOI 10.1002/iub.124 (2008).
23. Chen X, Sebastian BM, Nagy LE. Chronic ethanol feeding to rats decreases adiponectin secretion by subcutaneous adipocytes. Am. J. Physiol. Endocrinol. Metab. 292, E621-E628 (2007).
24. Xu A, Wang Y, Keshaw H, Xu LY, Lam KS, Cooper GJ. The fat-derived hormone adiponectin alleviates alcohol and non-alcoholic fatty liver disease in mice. J. Clin. Invest. 112, 91-100 (2003).
25. Song Z, Zhou Z, Deaciuc I, Chen T, McClain CJ. Inhibition of adiponectin production by homocysteine: a potential mechanism for alcoholic liver disease. Hepatology 47, 867-879 (2008).
26. Kang L, Sebastian BM, Pritchard MT, Pratt BT, Previs SF, Nagy LE. Chronic ethanol-induced insulin resistance is associated with macrophage infiltration into adipose tissue and altered expression of adiponectin. Alcohol Clin. Exp. Res. 31, 1581-1588 (2007).
27. Sanjal AJ. Mechanisms of disease: pathogenesis of non-alcoholic fatty liver disease. Nat. Clin. Pract. Gastroenterol. Hepatol. 2, 46-53 (2005).
28. Kang L, Chen X, Sebastian BM et al. Chronic ethanol and triglyceride turnover in white adipose tissue in rats: inhibition of the anti-lipolytic action of insulin after chronic ethanol contributes to increased triglyceride degradation. J. Biol. Chem. 282, 28465-28473 (2007).
29. He L, Marecki JC, Serrero G, Simmen FA, Ronis MJ, Badger TM. Dose-dependent effects of alcohol on insulin signaling: partial explanation for biphasic alcohol impact on human health. Mol. Endocrinol. 21, 2541-2550 (2007).
30. Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440, 944-948 (2006).
31. Shattemberg JM, Wang Y, Singh R, Rigoli RM, Czaja MJ. Hepatocyte CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insulin signaling. J. Biol. Chem. 280, 9887-9894 (2005).
32. Pessayre D, Fromenty B. NASH: a mitochondrial disease. J. Hepatol. 42, 982-940 (2005).
33. Noga AA, Zhao Y, Vance DE. An unexpected requirement for phosphatidylethanolamine N-methyltransferase in the secretion of very low density lipoproteins. J. Biol. Chem. 277, 42358-42365 (2002).
34. Kharbanda KK, Maillard ME, Baldwin CR, Beckenhauer HC, Sorell MF, Tuma DJ. Betaine attenuates alcoholic steatosis by restoring phosphatidylcholine generation via phosphatidylethanolamine methyltransferase pathway. J. Hepatol. 46, 314-321 (2007).
35. Pan M, Cederbaum AI, Zhang YL, Ginsberg HN, Williams KJ, Fisher EA. Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production. J. Clin. Invest. 113, 1277-1287 (2004).
36. Pritchard MT, McMullen MR, Stavitsky AB et al. Differential contribution of C3, C5 and decay accelerating factor to ethanol-induced fatty liver in mice. Gastroenterology 32, 1117-1126 (2007).
37. Bergheim I, Guo L, Davis MA et al. Metformin prevents alcohol induced liver injury in the mouse: critical role of plasminogen activator inhibitor-1. Gastroenterology 130, 2099-2112 (2006).
38. Hines IN, Wheeler MD. Recent advances in alcoholic liver disease III. Role of the innate immune response in alcoholic hepatitis. Am. J. Physiol. Gastrointest. Liver Physiol. 287, G310-G314 (2004).
39. Rao RK, Seth A, Sheth P. Recent advances in alcoholic liver disease I. Role of intestinal permeability and endotoxemia in alcoholic liver disease. Am. J. Physiol. Gastrointest. Liver Physiol. 286, G881-G884 (2004).
40. Gustot T, Lemmers A, Moreno C et al. Differential liver sensitization to Toll-like receptor pathway in mice with alcoholic fatty liver. Hepatology 43, 989-1000 (2006).
41. Hirtz I, Mandrekar P, Velayudham A et al. The critical role of Toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88. Hepatology 48, 1224-1231 (2008).
42. Nagy LE. Recent insights into the role of the innate immune system in the development of alcoholic liver disease. Exp. Biol. Med. 228, 882-890 (2003).
43. McMullen MR, Pritchard MT, Wang Q, Millward CA, Croniger CM, Nagy LE. Early growth response-1 transcription factor is essential for ethanol-induced fatty liver in mice. Gastroenterology 128, 2066-2076 (2005).
44. Gobejishvili L, Barve S, Joshi-Barve S, Uriarte S, Song Z, McClain C. Chronic ethanol-mediated decrease in cAMP primes macrophages to enhanced LPS-inducible NF-κB activity and TNF expression: relevance to alcoholic liver disease. Am. J. Physiol. Gastrointest. Liver Physiol. 291, G681-G688 (2006).
45. Jaeschke H. Neutrophil-mediated tissue injury in alcoholic hepatitis. Alcohol 27, 23-27 (2002).
46. Thakur V, Pritchard MT, McMullen MR, Wang Q, Nagy LE. Chronic ethanol feeding increases activation of NADPH oxidase by lipopolysaccharide in rat Kupffer cells: role of increased reactive oxygen in LPS-stimulated ERK1/2 activation and TNF-α production. J. Leukoc. Biol. 79, 1348-1356 (2006).
47. Hiriguchi N, Wang L, Mukhoppadhyay P et al. Cell type-dependent pro- and anti-inflammatory role of signal transducer activator of transcription 3 in alcoholic liver injury. Gastroenterology 134, 1148-1158 (2008).
48. Li Z, Soloski MK, Diehl AM. Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease. Hepatology 42, 880-885 (2005).
49. Tilg H, Moschen AR. Adipokines: mediators linking adipose tissue, inflammation and immunity. Nat. Rev. Immunol. 6, 4772-4783 (2006).
50. Naveau S, Perlemuter G, Chaillet M et al. Serum leptin in patients with alcoholic liver disease. Alcohol. Clin. Exp. Res. 30, 1422-1428 (2006).
51. Huang H, Park PH, McMullen MR, Nagy LE. Mechanisms for the anti-inflammatory effects of adiponectin in macrophages. J. Gastroenterol. Hepatol. 23(Suppl. 1), S50-S53 (2008).
52. Ramaiah SH, Ritting S. Role of osteopontin in regulating hepatic inflammatory responses and toxic liver injury. Expert Opin. Drug Metab. Toxicol. 3, 519-526 (2007).
53. Seth D, Gorrell MD, Cordoba S, McCaughan GW, Haber PS. Intrahepatic gene expression in human alcoholic hepatitis. J. Hepatol. 45, 306-320 (2006).
54. Colombat M, Charlotte F, Ratziu V, Poyard T. Portal lymphocytic infiltrate in alcoholic liver disease. Hum. Pathol. 33, 1170-1174 (2002).
55. Batey RG, Cao Q, Gould B. Lymphocyte-mediated liver injury in alcohol-related hepatitis. Alcohol 27, 37-41 (2002).
56. Vidali M, Stewart SF, Albano E. Interplay between oxidative stress and immunity in the progression of alcohol-mediated liver injury. Trends Mol. Med. 14, 63-71 (2008).
57. Thiele GM, Freeman TK, Klassen LW. Immunological mechanisms of alcoholic liver disease. Sem. Liver Dis. 24, 273-287 (2004).
58. Ma X, Hua J, Mohamood AR, Hamad ARA, Ravi R, Li Z. A high fat diet and regulatory T cells influence the susceptibility to endotoxin-induced liver injury. Hepatology 46, 1519-1529 (2007).
59. Ronis MJJ, Botura A, Korourian S et al. Cytokine and chemokine expression associated with steatohepatitis and hepatocyte proliferation in rats fed ethanol via total enteral nutrition. Exp. Biol. Med. 233, 344-355 (2008).
60. Ronis MJJ, Butura A, Sampey BP et al. Effects of N-acetyl cysteine on ethanol-induced hepatotoxicity in rats fed via total enteral nutrition. Free Rad. Biol. Med. 39, 619-630 (2005).
61. Vidali M, Vietala J, Occhino G et al. Immune responses against oxidative stress-derived antigens are associated with increased circulating tumor necrosis factor-α and accelerated liver damage in heavy drinkers. Free Rad. Biol. Med. 45, 306-311 (2008).
62. Natori S, Rust C, Stadheim LM, Srinivasan A, Burgart LJ, Gores GJ. Hepatocyte apoptosis is a pathological feature of human alcoholic hepatitis, J. Hepatol. 34, 248-253 (2001).
63. Adachi M, Higuchi H, Miura S et al. Bax interacts with voltage-dependent anion channel and mediates ethanol-induced apoptosis in rat hepatocytes. Am. J. Physiol. Gastrointest. Liver Physiol. 287, G695-G705 (2004).
64. - mice fed alcohol. Free Rad. Biol. Med. 42, 1470-1480 (2007).
65. Deniaud A, Sharaf el Dein O, Mailler E et al. Endoplasmic reticulum stress induces calcium-dependent permeability transition, mitochondrial outer membrane permeabilization and apoptosis. Oncogene 27, 285-299 (2008).
66. Tilg H, Day CP. Management strategies in alcoholic liver disease. Nat. Clin. Pract. Gastroenterol. Hepatol. 4, 24-34 (2007).
67. Schwabe RF, Brenner DA. Mechanisms of liver injury. I. TNF-α-induced liver injury: role of IKK, JNK and ROS pathways. Am. J. Physiol. Gastrointest. Liver Physiol. 290, G583-G589 (2006).
68. Fernandez-Checa JC, Kaplowitz N. Hepatic mitochondrial glutathione: transport and role in disease and toxicity. Toxicol. Appl. Pharmacol. 204, 263-273 (2005).
69. Mari M, Colell A, Morales A et al. Mechanism of mitochondrial glutathione-dependent hepatocellular susceptibility to TNF despite NF-κB activation. Gastroenterology 134, 1507-1520 (2008).
70. Song Z, Zhou Z, Uriarte S et al. S-adenosylhomocysteine sensitizes to TNF-α hepatotoxicity in mice and liver cells: a possible etiological factor in alcoholic liver disease. Hepatology 40, 989-997 (2004).
71. Hoek JB, Pastorino JG. Cellular signalling mechanisms in alcoholic liver damage. Sem. Liver Dis. 24, 257-272 (2004).
72. Shulga N, Hoek JB, Pastorino JG. Elevated PTEN levels account for the increased sensitivity of ethanol-exposed cells to tumor necrosis factor-induced cytotoxicity. J. Biol. Chem. 280, 9416-9424 (2005).
73. Sampey BP, Stewart BJ, Petersen DR. Ethanol-induced modulation of hepatocellular extracellular signal-regulated kinase 1/2 activity via 4-hydroxynonenal. J. Biol. Chem. 282, 1925-1937 (2007).
74. Krusko DV, D'Herde K, Vandenabeele P. Clearance of apoptotic and necrotic cells and its immunological consequences. Apoptosis 11, 1709-1726 (2006).
75. McVicker BL, Tuma DJ, Kubik JA, Hindemith AM, Baldwin CR, Casey CA. The effect of ethanol on asialoglycoprotein receptor-mediated phagocytosis of apoptotic cells by rat hepatocytes. Hepatology 36, 1478-1487 (2002).
76. Vay D, Rigamonti C, Vidali M et al. Anti-phospholipid antibodies associated with alcoholic liver disease target oxidized phosphatidylserine on apoptotic cell plasma membranes. J. Hepatol. 44, 183-189 (2006).
77. Michalopoulos GK. Liver regeneration. J. Cell. Physiol. 213, 286-300 (2007).
78. Diehl AM. Recent events in alcoholic liver disease V. Effect of ethanol on liver regeneration. Am. J. Physiol. Gastrointest. Liver Physiol. 288, G1-G6 (2005).
79. Omenetti A, Diehl AM. The adventures of sonic hedgehog in the development and repair II. Sonic hedgehog and liver development, inflammation and cancer. Am. J. Physiol. Gastrointest. Liver Physiol. 294, G595-G598 (2008).
80. Jung Y, Brown KD, Witek RP et al. Accumulation of hedgehog-responsive progenitors paralles alcoholic liver disease in mice and humans. Gastroenterology 134, 1532-1543 (2008).
81. Friedman SL. Mechanism of hepatic fibrogenesis. Gastroenterology 134, 1655-1669 (2008).
82. Novo E, Parola M. Redox mechanisms in hepatic chronic wound healing and fibrogenesis. Fibrogen Tissue Repair 1(1), 5 (2008).
83. Parola M, Marra F, Pinzani M. Myofibroblast-like cells and liver fibrogenesis: emerging concepts in a rapidly moving scenario. Mol. Asp. Med. 29, 58-66 (2008).
84. Marra F. Thiazolidinediones and hepatic fibrosis: don't wait too long. Gut 55, 917-919 (2006).
85. Wang J, Brymora J, George J. Role of adipokines in liver injury and fibrosis. Expert Rev. Gastroenterol. Hepatol. 2, 47-57 (2008).
86. Arteel GE. New role of plasminogen activator inhibitor-1 in alcoholic liver injury. J. Gastroenterol. Hepatol. 23(Suppl. 1), S54-S59 (2008).
87. Nieto N. Ethanol and fish oil induce NFκB transactivation of the collagen α2(1) promoter through lipid peroxidation-driven activation of PKC - PI3K - Akt pathway. Hepatology 45, 1433-1445 (2007).
88. 2-mediated c-Abl activation in human hepatic stellate cells. Gastroenterology 131. 1235-1253 (2006).
89. Tuma DJ. Role of malondialdehyde-acetaldehyde adducts in liver injury. Free Radic. Biol. Med. 32, 303-308 (2002).
90. Gao B, Radaeva S, Jeong W. Activation of NK cells inhibits liver fibrosis: a novel strategy to treat fibrosis. Expert Rev. Gastroenterol. Hepatol. 1, 173-180 (2007).
91. Jeong W, Park O, Gao B. Abrogation of anti-fibrotic effects of NK/ INF-γ contributes to alcohol acceleration of liver fibrosis. Gastroenterology, 134, 248-258 (2008).
92. Mallat A. Lotersztajn S. Endocannabinoids and liver disease. I. Endocannabinoids and their receptors in the liver. Am. J. Physiol. Gastrointest. Liver Physiol. 294, G9-G12 (2008).
93. Jeong WT, Osei-Hyiaman D, Park O et al. Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver. Cell Metab. 7, 227-235 (2008).
94. Texeira-Clerc F, Julien B, Grenard P et al. CB1 cannabinoids receptor antagonism: a new strategy for the treatment of liver fibrosis. Nat. Med. 12, 671-676 (2006).
95. Nieto N, Rojkind M. Repeated whiskey binges promotes liver injury in rats fed a choline-deficient diet. J. Hepatol. 46, 330-339 (2007).
96. Kamada Y, Tamura S, Kiso S et al. Enhanced carbon tetrachloride-induced fibrosis in mice lacking adiponectin. Gastroenterology 125, 1796-1807 (2003).